OC50 2023: Thomas Burns
THOMAS BURNS CHAIRMAN, CEO GLAUKOS WHY: Chief executive, director since 2002 of medical device maker that treats glaucoma, one of the world's leadi...
October 5, 2023
3:30 AM
THOMAS BURNS CHAIRMAN, CEO GLAUKOS WHY: Chief executive, director since 2002 of medical device maker that treats glaucoma, one of the world's leading causes of blindness. Aliso Viejo's most valuable public company, best known for the iStent, among the smallest medical devices ever made. FUTURE PLANS: New products include tiny eye implant, iDose TR, that for as long as three years releases into the anterior chamber a proprietary formulation of travoprost, a medicine used to lower intraocular pressure.